Cardiovascular risk in gout: time for action

Lancet Rheumatol. 2024 Mar;6(3):e131-e132. doi: 10.1016/S2665-9913(24)00023-7.

Authors

Abhishek Abhishek¹, Edoardo Cipolletta²

Affiliations

¹ Academic Rheumatology, University of Nottingham, Nottingham, NG5 1PB, UK. Electronic address: abhishek.abhishek@nottingham.ac.uk.
² Academic Rheumatology, University of Nottingham, Nottingham, NG5 1PB, UK; Rheumatology Unit, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy.

PMID: 38383083
DOI: 10.1016/S2665-9913(24)00023-7

No abstract available

MeSH terms

Cardiovascular Diseases* / epidemiology
Gout* / complications
Heart Disease Risk Factors
Humans
Hyperuricemia*
Risk Factors